ArticleVeterinary medicine and science2026
Antimicrobial Susceptibility Profiles of Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolated From Intensively Reared and Free-Range Chickens in Selected Districts of Zambia.
Article in Veterinary medicine and science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundExtended-spectrum β-lactamase (ESBL)-producing Escherichia coli in poultry is an emerging One Health concern, yet comparative data on intensive versus free-range systems in sub-Saharan Africa remain sparse.
objectivesTo compare the prevalence, susceptibility profiles and β-lactamase gene content of ESBL-producing E. coli from intensively reared and free-range chickens in Central Province, Zambia.
methodsIn a cross-sectional study (March-April 2021), 112 pooled faecal samples (56 per production system; 10 birds per sampling point) were collected across seven veterinary camps in Kabwe and Kapiri Mposhi districts and processed within 24 h. Presumptive ESBL E. coli was isolated on MacConkey agar with 2 mg/L cefotaxime and identified biochemically. Susceptibility to 11 antimicrobials was tested by Kirby-Bauer disc diffusion per CLSI M100 (2020), and ESBL production was confirmed by combination-disc synergy. bla
resultsESBL-producing E. coli was recovered from 13/112 pooled samples (11.6%, 95% CI: 6.9%-18.9%), with no difference between intensively reared (7/56, 12.5%) and free-range (6/56, 10.7%) chickens (p = 1.00). All 13 isolates were multidrug-resistant, with the highest resistance to tetracycline and cefotaxime (both 100%), streptomycin (84.6%) and sulfamethoxazole-trimethoprim (69.2%). bla
conclusionsMultidrug-resistant, bla
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.